openPR Logo
Press release

Antiviral Drugs Market Top Trends 2027 | Top Players F. Hoffmann-La Roche AG, GlaxoSmithKline plc, AbbVie, Johnson & Johnson

04-29-2021 12:35 PM CET | Health & Medicine

Press release from: Global Market Insight, Inc

With extensive research and development activities as well as growing drug approvals, the antiviral drugs market is expected to procure commendable growth strides until 2027. There is a rise in the number of medical product approvals via collaborations and licensing worldwide. The occurrence of disease outbreaks such as Zika virus, Ebola virus and the coronavirus infections has driven the usage of antiviral drugs as a potential treatment.

There is a pressing need for continuous advancements and development in antiviral drugs, as viruses are quickly developing their structure against the environment and boosting their tolerance towards drugs. With the recent outbreak of COVID-19, governments are raising their funding capacity for pharmaceutical companies to make antiviral medications.

Request for a sample copy of this report @

Firms specializing in antiviral drugs are also focusing on new product development. For example, in 2020, Gilead Sciences announced FDA approval of its investigational antiviral drug, remdesivir, for emergency use in the treatment of COVID-19.

A report by Global Market Insights, Inc., states that the antiviral drugs market registered over USD 44 billion in 2020 and is projected to witness a -1.7% CAGR by 2027.

In terms of drug class, the reverse transcriptase inhibitors segment held over 40% of the industry share in 2020. Reverse transcriptase inhibitors are drug types which are classified as non-nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors (NRTI). Some of the drugs under the extensive portfolio of NNRTIs and NRTIs are Intelence, Atripla, Odefsey, Biktarvy, Descovy, and Complera, developed against retroviruses.

Surge in the launch of new generic medications could fare the prospects of generic antiviral drugs sector over the forecasted period. Generic antiviral drugs are being rapidly adopted for pre-exposure prophylaxis and treatment offering cost advantage to patients. Moreover, cost-effective generic versions of branded drugs raise treatment coverage due to less affordability of high cost drugs within middle and low income classes having less resources.

In terms of age group, the geriatric segment accounted for above 40% share in 2020 given to the high cost of treatment for elderly population and the prevalence of chronic diseases such as diabetes. The geriatric population is mostly vulnerable to infectious diseases and also is prone to high mortality especially since the coronavirus pandemic.

Request for customization @

Companies develop antiviral drugs for such patient groups include Johnson & Johnson, AbbVie, Merck & Co., Gilead Sciences, AstraZeneca, and GlaxoSmithKline. These organizations are working on product innovations and partnerships, among others. In 2020, AstraZeneca announced its collaboration with several countries and multilateral organizations to make the University of Oxford’s vaccine extensively accessible across the globe in an equitable way.

Partial Chapter of the Table of Content

Chapter 4 Anti-viral Drugs Market, By Drug Class

4.1 Key segment trends

4.2 DNA polymerase inhibitors

4.2.1 Market size, by region, 2016 – 2027 (USD Million)

4.3 Reverse transcript inhibitors

4.3.1 Market size, by region, 2016 – 2027 (USD Million)

4.4 Protease inhibitors

4.4.1 Market size, by region, 2016 – 2027 (USD Million)

4.5 Neuraminidase Inhibitors

4.5.1 Market size, by region, 2016 – 2027 (USD Million)

4.6 Others

4.6.1 Market size, by region, 2016 – 2027 (USD Million)

Chapter 5 Anti-viral Drugs Market, By Indication

5.1 Key segment trends

5.2 Influenza

5.2.1 Market size, by region, 2016 – 2027 (USD Million)


5.3.1 Market size, by region, 2016 – 2027 (USD Million)

5.4 Hepatitis

5.4.1 Market size, by region, 2016 – 2027 (USD Million)

5.5 Herpes simplex virus (HSV)

5.5.1 Market size, by region, 2016 – 2027 (USD Million)

5.6 Coronavirus infection

5.6.1 Market size, by region, 2016 – 2027 (USD Million)

5.7 Others

5.7.1 Market size, by region, 2016 – 2027 (USD Million)

Browse full table of contents (TOC) of this report @

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688

About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiviral Drugs Market Top Trends 2027 | Top Players F. Hoffmann-La Roche AG, GlaxoSmithKline plc, AbbVie, Johnson & Johnson here

News-ID: 2277399 • Views: 346

More Releases from Global Market Insight, Inc

Inhalation Anesthesia Market Projections 2025 | Abbott, Baxter International, Halocarbon Products
Inhalation Anesthesia Market Projections 2025 | Abbott, Baxter International, Ha …
Global inhalation anesthesia market is poised to gain massive momentum over the forecast period of 2019 to 2025. This can be credited to the significant rise in product adoption primarily driven by increasing surgical procedures related to respiratory, neurological and chronic disorders. Additionally, supportive reimbursement scenario across developed countries and availability of several insurance schemes for quick and affordable surgical procedures will increase the application of inhalational anesthetics, thereby supporting
Health Insurance Market Trends 2025 | Aetna, Blue Cross Blue Shield Companies, Cigna, Highmark, HCSC
Health Insurance Market Trends 2025 | Aetna, Blue Cross Blue Shield Companies, C …
Regular occurrences of long-term diseases will bolster the health insurance industry trends in the next few years. This rise can be attributed to the changing dietary habits, lack of physical activities, poor nutrition, excessive alcohol use, and tobacco consumption. Various Government-backed initiatives by several programs like State Children's Health Insurance Program, Medicaid, Life programs, Department of Defense, TRICARE are employed to provide health insurance policies. Centers for Medicare & Medicaid
Ambulance Services Market Outlook 2021-2026 | Acadian Ambulance Service, BVG India Limited
Ambulance Services Market Outlook 2021-2026 | Acadian Ambulance Service, BVG Ind …
The global ambulance services market is estimated to foresee momentous growth through the forthcoming time period owing to an upsurge in road accidents. Additionally, the growing prevalence of chronic diseases and increasing medical tourism trend is further slated to augment the overall market size through 2026. Additionally, the introduction of new ambulance models and launch of new technologies that focus on the enhancement of ambulatory care is likely to proliferate
Biosimilars Market Forecast 2025 | Amgen, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Coherus BioSciences
Biosimilars Market Forecast 2025 | Amgen, Biocon, Biogen, Boehringer Ingelheim, …
Touted to be an intrinsic sub-vertical of healthcare and medical devices industry, biosimilars market is poised to record phenomenal gains in the upcoming years owing to the fact that these play a pivotal role in augmenting public health issue by addressing the customer needs to a much larger extent. Numerous reports suggest that biosimilars would result in overall potential savings of nearly USD 100 billion by the end of 2020,

All 5 Releases

More Releases for USD

$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - There is a $3,000,000
Primary Alkaline Batteries Market Worth USD 14.58 Billion USD by 2026
The Global Primary Alkaline Batteries market size was valued at 10.31 Billion USD in 2019 and is projected to reach 14.58 Billion USD by 2026, at a CAGR of 5% during the forecast period. An Primary Alkaline Batteries is a type of primary battery, which derives its energy from the reaction between zinc metal and manganese dioxide. Get Detailed Analysis of COVID-19 Impact on Primary Alkaline Batteries Market @ This report presents
IOT Solutions Market worth USD 553.9 million USD by 2026
"The global IoT solutions market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cybersecurity as a service market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa." These days many businesses are adopting a market research report
Eubiotics Market Set to Exceed USD USD 8.60 Billion by 2026
According to a new study published by Polaris Market Research the global eubiotics market is anticipated to reach USD 8.60 billion by 2026. The tightening and stringent restrictions on the use of antibiotic growth promoters along with the surging consumer pressure on food safety and consumer preferences are expected to be the major factors driving demand for these products that work as substitutes to in-feed eubiotics. Eubiotics or specific organic
Polyurethane Dispersions Market worth USD 2.04 Billion USD by 2020
The report " Polyurethane Dispersions Market by Type (Water-Based Polyurethane Dispersions and Solvent-Based Polyurethane Dispersions), by Application (Coatings, Adhesives & Sealants, Synthetic Leather Production, Fiber Glass Sizing, and Others) - Trends & Forecasts to 2020", The global polyurethane dispersions market is projected to reach USD 2.04 Billion by 2020 at a CAGR of 6.8% between 2015 and 2020. This growth is fueled by the high potential from the textile and
Retail Analytics Market worth USD 5.1 Billion USD by 2020
According to a new market research report "Retail Analytics Market by Business Function (Marketing and Customer Analytics, Merchandizing and In-Store Analytics, Supply Chain Analytics, Strategy and Planning), by Type, by Solutions and by Services - Global Forecast and Analysis to 2020", defines and segments the global retail analytics market on the basis of business function, solutions, services, deployment types, and regions along with providing an in-depth analysis and market size